{"id":6822,"date":"2015-09-11T10:14:43","date_gmt":"2015-09-11T10:14:43","guid":{"rendered":"\/?p=6822"},"modified":"2015-09-11T10:39:30","modified_gmt":"2015-09-11T10:39:30","slug":"cell-medx-corp-otcbbcmxc-wakes-up","status":"publish","type":"post","link":"\/articles\/cell-medx-corp-otcbbcmxc-wakes-up\/","title":{"rendered":"Cell MedX Corp (OTCBB:CMXC) Wakes Up"},"content":{"rendered":"\n

Cell MedX Corp (OTCBB:CMXC<\/a>) logged a 52-week high of over $0.80 per share in January, but unfortunately, there wasn’t much to suggest that it can remain there for long. The financial statements were showing lack of cash and revenues and the news wasn’t particularly encouraging. Last but not least, the ticker was being pumped by the infamous Charles Moskowitz who was saying that if you were to invest $5,000 in CMXC<\/a><\/strong>, you would eventually be able to walk away with $74,500. <\/p>\n

The people who invested $5,000 when CMXC<\/a><\/strong> was hovering near its 52-week high now have shares that are worth about $1,360. Nevertheless, the ticker is moving. CMXC<\/a><\/strong> was sitting at $0.22 per share when yesterday’s closing bell rang which represents only a 5% increase on Tuesday’s value. It did, however, make some rather interesting swings throughout the day and it also logged a dollar volume of just under $170 thousand which means that we have to ask the same question we were asking eight months ago: “Can CMXC<\/a><\/strong> remain calm at these levels?<\/em>”.<\/p>\n

The company filed its annual report for the period ended May 31 last week, so it’s only natural to start looking for the answer by examining the financials. Here they are:<\/p>\n